DIRS.INFO The most relevant business & tech news

☆ Oppenheimer's best small and mid-cap stock ideas to play the market broadening
▼ + stars: | 2024-07-11 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailOppenheimer's best small and mid-cap stock ideas to play the market broadeningJed Kelly, Managing Director of Equity Research at Oppenheimer, discusses his bull thesis for Genius Sports.

Persons: Jed Kelly Organizations: Equity Research, Oppenheimer, Genius Sports

☆ The best small- and midcap stocks to buy this summer, according to Oppenheimer
▼ + stars: | 2024-07-10 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

With the second half of the year underway, Oppenheimer is highlighting what it calls its top small- and midcap seasonal standout investment ideas. On the basis of price charts alone, Oppenheimer tapped midcap growth stocks as its top rotation idea from a technical perspective. Oppenheimer has a $20 price target on Zeta, implying 18% upside from Tuesday's close. In a note last month, RBC Capital Markets also rated Zeta outperform with a price target of $20. In this area, Oppenheimer likes Viking Therapeutics , reiterating the stock as one of its best ideas.

Persons: Oppenheimer, Russell, Brian Schwartz, Zeta, Novo Nordisk's Wegovy, Eli Lilly's Zepbound, Jay Olson, Freshpet Organizations: Oppenheimer, Zeta Global Holdings, Zeta, RBC Capital Markets, Novo Nordisk's, Viking Therapeutics, Therapeutics Locations: Zeta, Novo

☆ Wall Street is getting even more bullish on stocks
▼ + stars: | 2024-07-09 | by ( Filip De Mott | ) www.businessinsider.com time to read: +3 min

Oppenheimer raised its year-end S&P 500 target to 5,900, the second-highest target on Wall Street. The shift makes the firm the second-most bullish on Wall Street. "Just like before, it's a matter of the fundamentals, where they stand right now," John Stoltzfus, Oppenheimer's chief investment strategist, told CNBC. A handful of tech stocks have been doing the heavy lifting for the benchmark index, giving investors pause about how sustainable the current rally is. Correction: July 9, 2024 — An earlier version of this story misstated the date from which Oppenheimer's target indicates 6% upside.

Persons: Oppenheimer, John Stoltzfus, —, Stoltzfus, It's, Goldman Sachs, Marko Kolanovic — Organizations: Service, CNBC, Security, Federal Reserve, UBS, JPMorgan . Locations: Monday's

☆ 14 stocks to buy for at least 25% earnings growth in 2025 while the stunning market rally stalls, according to Goldman Sachs
▼ + stars: | 2024-07-09 | by ( James Faris | ) www.businessinsider.com time to read: +4 min

The most bullish year-end target for the S&P 500 was 5,100, which represented solid upside of about 7% from where it ended the year. Those predictions look paltry in hindsight, as the S&P 500 finished the first half of the year up 14.5% at 5,460. Bulls are getting bolder, but risks remainIn response, several major firms have boosted their year-end S&P 500 targets in recent months. AdvertisementGoldman Sachs recently shared earnings growth projections for the 100 biggest stocks in the S&P 500, both for this year and next. Below are those 14 large-cap stocks expected to grow earnings by at least 25% next year, along with each one's ticker, market capitalization, and 2024 and 2025 earnings growth estimates.

Persons: —, Goldman Sachs, Morgan Stanley, Oppenheimer's John Stoltzfus, David Kostin, Kostin Organizations: Service, Business, Bulls, BMO Capital Markets, Deutsche Bank, Apple, Meta, Microsoft, Nvidia —

☆ Oppenheimer raises S&P 500 target to 5,900
▼ + stars: | 2024-07-08 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailOppenheimer raises S&P 500 target to 5,900John Stoltzfus, Oppenheimer Asset Management chief investment strategist, joins 'Money Movers' to discuss his new target for the S&P 500, what could start to show up in Q2 regarding Oppenheimer's target hike, and much more.

Persons: Oppenheimer, John Stoltzfus Organizations: Oppenheimer Asset Management

☆ CNBC Daily Open: U.S. seeks Boeing guilty plea
▼ + stars: | 2024-07-01 | by ( Abid Ali | ) www.cnbc.com time to read: +3 min

This report is from today's CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. On Friday, the S&P 500 and Nasdaq hit record highs before pulling back. Boeing 'guilty plea'U.S. prosecutors plan to seek a guilty plea from Boeing over a charge related to two fatal 737 Max crashes in 2018 and 2019, attorneys for the victims' family members said. [PRO] Rally will broadenThe tech sector has driven market performance in 2024, with the S&P 500 tech group up 28% and Nvidia soaring 149%, while small-caps have lagged.

Persons: Max, John Donahoe, Morgan Stanley, Stifel, Gregory Greene, Mary Daly, CNBC's Andrew Ross Sorkin, John Stoltzfus, Lisa Kailai Han Organizations: Dow Jones, Nasdaq, CNBC, Hezbollah, Boeing, U.S, The Justice, DOJ, Nike, Federal Reserve, San Francisco Fed, Nvidia Locations: Israel, Iran, Gox, Japanese

☆ Chewy's outlook is still mixed, says Oppenheimer's Rupesh Parikh
▼ + stars: | 2024-07-01 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailChewy's outlook is still mixed, says Oppenheimer's Rupesh ParikhRupesh Parikh, Oppenheimer, joins 'Closing Bell' to discuss Chewy's stock following a dog post by Roaring Kitty.

Persons: Oppenheimer's, Parikh, Oppenheimer, Roaring Kitty

☆ Nagel: This is likely the last bad report for Nike, a clearing event
▼ + stars: | 2024-06-28 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNagel: This is likely the last bad report for Nike, a clearing eventOppenheimer's Brian Nagel discusses Nike's disappointing quarter and whether the company will be able to leverage events like the Paris Olympics to boost sales.

Persons: Email Nagel, Brian Nagel Organizations: Nike, Paris Olympics

☆ Here are Oppenheimer's top stock picks heading into July
▼ + stars: | 2024-06-25 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

Oppenheimer unveiled its top stock ideas heading into a new trading month, all of which are seen outperforming over the next 12 months in the market's current conditions. While Oppenheimer has a price target at $75 for the stock, implying about 8.9% upside from Monday's close, JPMorgan is even more bullish. With a $116 price target, Oppenheimer sees similar gains still ahead. Oppenheimer has its price target set at $2,000, which implies a 25.6% increase from Monday's close. On Monday, it hiked Broadcom's price target to $2,150 and said the buy-rated stock is a top pick.

Persons: Oppenheimer, Jefferies, Rick Schafer, Goldman Sachs Organizations: United Therapeutics, Walmart, JPMorgan, Broadcom, Bank of America, Dick's Sporting Goods Locations: Centene, United

☆ Oppenheimer's John Stoltzfus: We're still very much in a bull market supported by fundamentals
▼ + stars: | 2024-06-21 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailOppenheimer's John Stoltzfus: We're still very much in a bull market supported by fundamentalsJohn Stoltzfus, Oppenheimer Asset Management chief investment strategist, joins 'Squawk Box' to discuss the latest market trends, why he believes the Fed is unlikely to cut rates this year, why he remains positive on equities, and more.

Persons: John Stoltzfus Organizations: Oppenheimer Asset Management

☆ Room for upward adjustment to our Apple price target, says Oppenheimer's Martin Yang
▼ + stars: | 2024-06-14 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailRoom for upward adjustment to our Apple price target, says Oppenheimer's Martin YangMartin Yang, Oppenheimer senior analyst, joins 'Squawk on the Street' to discuss whether it's time to readjust Apple's price target, what the analyst expects from Apple's revenues, and more.

Persons: Oppenheimer's Martin Yang Martin Yang, Oppenheimer

☆ Brought utilities up to market perform from underperform, notes Oppenheimer's Stoltzfus
▼ + stars: | 2024-05-28 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBrought utilities up to market perform from underperform, notes Oppenheimer's StoltzfusJohn Stoltzfus, Oppenheimer Asset Management chief investment strategist, joins 'Squawk on the Street' to discuss the strategist's portfolio changes, the sectors Stoltzfus is favoring, and how the Federal Reserve factors into the investor's strategy.

Persons: Oppenheimer's Stoltzfus John Stoltzfus Organizations: Oppenheimer Asset Management, Federal

☆ Oppenheimer's Brian Nagel reacts to Lowe's earnings
▼ + stars: | 2024-05-21 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailOppenheimer's Brian Nagel reacts to Lowe's earningsBrian Nagel, Oppenheimer senior equity research analyst, joins 'Squawk Box' to discuss Lowe's quarterly earnings results and more.

Persons: Brian Nagel, Oppenheimer

☆ This restaurant chain specializing in salads is primed to surge nearly 50%, Oppenheimer says
▼ + stars: | 2024-05-07 | by ( Brian Evans | ) www.cnbc.com time to read: +1 min

The firm reiterated an outperform rating on the restaurant chain stock and listed it as a top pick. Oppenheimer's $34 per share price target implies nearly 50% upside from Monday's $22.74 close. "We believe the model is in the early innings of a powerful earnings revision cycle," analyst Brian Bittner wrote Monday. Bittner, however, sees Sweetgreen reporting a smaller-than-expected loss due to strong margins. However, "our work suggests now is the time to get aggressive as the model transitions to sustainable EBITDA profitability starting in 2024."

Persons: Oppenheimer, Sweetgreen, Brian Bittner, Sweetgreen's, Bittner Organizations: FactSet

☆ Friday's analyst calls: Street reacts to Apple buybacks and Coinbase earnings
▼ + stars: | 2024-05-03 | by ( Alex Harring | ) www.cnbc.com time to read: +12 min

Analyst Scot Ciccarelli upgraded the retailer to buy from hold and raised his price target by $6 to $86. — Alex Harring 6: 22 a.m.: Here's what Wall Street thinks of Coinbase's earnings Coinbase's stronger-than-expected earnings have prompted analyst reactions. Barclays' Benjamin Budish (underweight, $179 price target unchanged, 21.8% downside): "The biggest question going forward is, how sustainable are these trends? — Alex Harring 6:12 a.m.: Wall Street reacts to Apple earnings Apple's buyback announcement has caught the eye of Wall Street analysts. Analyst Benjamin Nolan upgraded the railroad stock to buy from hold and increased his price target by $19 to $267.

Persons: Morgan Stanley, Jefferies, Bernstein, Aneesha Sherman, Sherman, — Alex Harring, Truist, Scot Ciccarelli, Ciccarelli, Ollie's, Estee Lauder, Dara Mohsenian, Mohsenian, Alex Harring, FactSet, Coinbase, what's, —, Goldman Sachs, Will Nance, Benjamin Budish, Oppenheimer's Owen Lau, JPMorgan's Samik Chatterjee, Morgan Stanley's Erik Woodring, Michael Ng, bullish, George Notter, Notter, We've, it's, Stifel, Benjamin Nolan, Nolan, — Alex Harring —, Michael Bloom Organizations: CNBC, Arista and Union Pacific, Apple, Arista, FactSet, Barclays, Bloomberg, ASU, Street, Services, Jefferies, Arista Networks, Nvidia, Microsoft, Meta, Pacific, Union Pacific Locations: F3Q, China, Thursday's

☆ Now's the time to buy Meta shares if you're a long-term investor: Oppenheimer's Jason Helfstein
▼ + stars: | 2024-04-25 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNow's the time to buy Meta shares if you're a long-term investor: Oppenheimer's Jason HelfsteinJason Helfstein, Oppenheimer, joins 'Squawk on the Street' to discuss if Meta's concerns are about growth or spend, if Mark Zuckerberg has earned the right to be called a disciplined spender, and more.

Persons: Oppenheimer's Jason Helfstein Jason Helfstein, Oppenheimer, Mark Zuckerberg, spender

☆ Tesla's as much a story stock as it is a reality stock at this point, says Oppenheimer's Colin Rusch
▼ + stars: | 2024-04-24 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTesla's as much a story stock as it is a reality stock at this point, says Oppenheimer's Colin RuschColin Rusch, Oppenheimer senior research analyst, joins 'Squawk Box' to discuss Tesla's quarterly earnings results, growth outlook, Elon Musk's long-term strategy for the company, shift in buyer base, and more.

Persons: Colin Rusch Colin Rusch, Oppenheimer, Elon Musk's

☆ The stock market is primed for a short-term bounce, but correction still not over
▼ + stars: | 2024-04-22 | by ( Sarah Min | ) www.cnbc.com time to read: +4 min

The stock market is poised for a short-term bounce, but technical analysts who watch price charts warn that the correction is not yet over. The technician said he anticipates support for stocks — the point at which buyers will reemerge — between 4,700-4,800 in the S & P 500. .SPX YTD mountain S & P 500 To be sure, some observers anticipate a more durable stock market rally, rather than a mere bounce. He anticipates that the S & P 500 could find support down at 4,800 and may not find a true bottom for several weeks. But he anticipates that the selloff will take longer to play out, with a pullback bringing the S & P 500 back to 4,700.

Persons: JC O'Hara, Roth MKM, O'Hara, Tom Lee, Lee, CNBC's, Oppenheimer's Ari Wald, Wald, we've, BTIG's Jonathan Krinsky, Krinsky, Wolfe's Rob Ginsberg Organizations: Stocks, Federal Reserve

☆ Oppenheimer's Chris Kotowski breaks down Goldman Sachs' Q1 earnings
▼ + stars: | 2024-04-15 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailOppenheimer's Chris Kotowski breaks down Goldman Sachs' Q1 earningsChris Kotowski, Oppenheimer analyst, joins 'Squawk on the Street' to discuss Goldman Sachs' quarterly earnings results, how the bank measures with competition, and what to expect from the financials going forward.

Persons: Chris Kotowski, Goldman Sachs, Oppenheimer

Other analysts saw upside for Coinbase and DoorDash along with Meta Platforms, as the social network builds advertising market share. The firm initiated coverage of DoorDash stock with a buy rating and a $165 per share price target. The analyst reiterated his overweight rating on Tesla stock but lowered his price target slightly to $310 per share from $320. The firm reiterated a buy rating on Meta stock and raised its price target to $585 per share from $550 on Thursday. Meta stock has surged more than 43% in 2024.

Persons: Morgan Stanley, Pamela Kaufman, Kaufman, — Jesse Pound, Mark Zgutowicz, — Brian Evans, Oliver Wintermantel, Wintermantel, Brian Evans, Morgan Stanley's Adam Jonas, Morgan Stanley's, Adam Jonas, Tesla's, Jonas, Tesla, — Brian Evans TSLA, Oppenheimer, Coinbase, Owen Lau, Jefferies, Brent Thill, outgrow Amazon's, Meta, Thill, Erika Najarian, Najarian, BofA's Organizations: CNBC, Jefferies, Bank of America, UBS, Big Four, Meta, Hershey, ISI, Tesla Network, 2Q, Amazon, UBS downgrades Bank of America Locations: Big Four U.S, Hershey, cryptocurrency, Wednesday's, 2H24

☆ Wall Street could be in for another good quarter after an exuberant start to the year, history shows
▼ + stars: | 2024-03-28 | by ( Sarah Min | ) www.cnbc.com time to read: +7 min

Wall Street could be in for another solid quarter as stocks have embarked on a strong start to the year. Specifically, in the second quarter, the S & P 500 was higher 9 out of 11 times, averaging a 2.7% gain. Significantly, two occurrences of those 10% first-quarter gains Detrick reviewed took place during election years, with the S & P 500 ending higher on the year. In 1976, the S & P 500 went on to register a 1.5% increase in the second quarter, and a 4.6% jump for the rest of the year. The Wall Street firm maintained its year-end S & P 500 target of 5,050, representing a 3.8% slide from Wednesday's close.

Persons: Ryan Detrick, We've, there'd, Detrick, CNBC's, Research's Sam Stovall, Stovall, Piper Sandler, Craig Johnson, Brian Nick, Nick, John Stoltzfus, Ayako Yoshioka, Yoshioka, CFRA's Stovall, FactSet Organizations: Nvidia, VanEck Semiconductor, Dow Jones, Carson Group, Macro, PMI, Manufacturing, ADP, Survey, Services PMI, Weston Holdings, Conagra Brands, Consumer Credit Locations: U.S

☆ There's a new biggest bull on Wall Street, and he sees the S&P 500 rising to 5,500
▼ + stars: | 2024-03-25 | by ( Alex Harring | ) www.cnbc.com time to read: +3 min

Oppenheimer's John Stoltzfus has reclaimed his place as the most optimistic when it comes to year-end S & P 500 targets. Stoltzfus, the firm's chief investment strategist, hiked his forecast for the S & P 500 to 5,500 from 5,200. He had the highest target price heading into the year at 5,200, but was outdone as some beat him to increasing their forecasts. Stoltzfus also increased his earnings projection for the S & P 500 in 2024 by $10 to $250, making him tied for another Street high. The benchmark S & P 500 has climbed nearly 10% so far in the new year.

Persons: Oppenheimer's John Stoltzfus, Stoltzfus, JPMorgan's Dubravko Organizations: CNBC Pro, Social Security, CNBC

☆ Wall Street shrugs off the inflation report — plus, updates from a key health-care stock
▼ + stars: | 2024-03-12 | by ( Jeff Marks | ) www.cnbc.com time to read: +5 min

GE Healthcare updates: GE Healthcare CFO Jay Saccaro spoke at Oppenheimer's annual Healthcare MedTech & Services conference. Saccaro expects GE Healthcare to commence stock buybacks at some point, but that's still down the road. GE Healthcare shares fell about 1% Tuesday, but the move doesn't seem tied to the presentation. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Jay Saccaro, Saccaro, that's, Jim Cramer's, Jim, Yi Haifei Organizations: CNBC, Oracle, Nvidia, Nasdaq, GE Healthcare, GE, Services, U.S, Jim Cramer's Charitable Trust, Jim Cramer's Charitable, Fair for Trade, China National Convention Center, China News Service, Getty Locations: China, Williams, Sonoma, Beijing

☆ We're bracing for more choppiness in the market ahead as AI trade wobbles
▼ + stars: | 2024-03-11 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

Many observers are arguing that some pockets of the market, mainly in the AI trade, have moved too far, too fast and are ripe for pullbacks. Meanwhile, we'll be keeping an eye on Club holding GE Healthcare's appearance Tuesday at Oppenheimer's MedTech and Services conference. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, industrials, there's, we'll, Oppenheimer's, Jim Cramer's, Jim Organizations: CNBC, Nvidia, Club, Linde, Nasdaq, FMC Corp, Procter, Gamble, Truist, Energy, EQT Corp, Boeing, of Justice, Alaska Airlines, Howmet Aerospace, Tech, Oracle, GE, Services, Jim Cramer's Charitable Locations: Albemarle, Newmont

☆ Meet the real J. Robert Oppenheimer's family, including his wife Kitty, his 2 children, and his grandchildren
▼ + stars: | 2024-03-08 | by ( Eammon Jacobs | ) www.businessinsider.com time to read: +1 min

Cillian Murphy plays J. Robert Oppenheimer in Christopher Nolan 's "Oppenheimer." download the app Email address Sign up By clicking “Sign Up”, you accept our Terms of Service and Privacy Policy . AdvertisementChristopher Nolan's latest movie, "Oppenheimer," sees Irish actor Cillian Murphy play J. Robert Oppenheimer, the man responsible for leading the Manhattan Project and creating the atomic bomb for the United States during World War II. It also won seven awards at the 2024 BAFTAS, with Cillian Murphy and Robert Downey Jr. taking home awards for best actor and best supporting actor, respectively. As well as Oppenheimer's nuclear work, the film looks at the scientist's complex personal life, including his marriage to Katherine "Kitty" Oppenheimer, née Puening.

Persons: Cillian Murphy, J, Robert Oppenheimer, Christopher Nolan, Oppenheimer, —, Christopher Nolan's, He's, Robert Downey Jr, Katherine, Kitty, née Organizations: Service, Manhattan Locations: United States, Hiroshima, Nagasaki, Japan

Search resuls for: "Oppenheimer's"

25 mentions found